v3.26.3
Shareholders' Equity - Schedule of Share Options Granted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Jun. 30, 2026
Sep. 30, 2026
Non-Employee [Member]    
Schedule of Share Options Granted [Line Items]    
Number, Share options outstanding at beginning of period   9,380
Weighted average exercise price, Share options outstanding at beginning of period   $ 7.14
Weighted average remaining contractual terms (in years), Share options outstanding balance 3 years 5 months 15 days 3 years 2 months 15 days
Aggregate intrinsic value price, Share options outstanding at beginning of period   $ 7
Number, Share options outstanding at end of the period 9,380 9,380
Weighted average exercise price, Share options outstanding at end of the period $ 7.14 $ 7.14
Aggregate intrinsic value price, Share options outstanding at end of the period $ 7 $ 3
Number, Share options vested and exercisable   9,380
Weighted average exercise price, Share options vested and exercisable   $ 7.14
Weighted average remaining contractual terms (in years), Share options vested and exercisable   3 years 2 months 15 days
Aggregate intrinsic value price, Share options vested and exercisable   $ 3
CEO And Directors [Member]    
Schedule of Share Options Granted [Line Items]    
Number, Share options outstanding at beginning of period   164,665
Weighted average exercise price, Share options outstanding at beginning of period   $ 12.2
Weighted average remaining contractual terms (in years), Share options outstanding balance 1 year 7 days 10 months 28 days
Number, Share options expired   (10,463)
Weighted average exercise price, Share options expired   $ 8.96
Weighted average remaining contractual terms (in years), Share options expired  
Number, Share options outstanding at end of the period 164,665 154,202
Weighted average exercise price, Share options outstanding at end of the period $ 12.2 $ 12.42
Number, Share options vested and exercisable   154,202
Weighted average exercise price, Share options vested and exercisable   $ 12.42
Weighted average remaining contractual terms (in years), Share options vested and exercisable   10 months 28 days